An almost 3 billion Forints generic pharmaceutical development is to be finished this year at the TEVA Pharmaceutical Industries Ltd.
The project was made possible from 842 million Forints that were provided by the government in the frames of the New Széchenyi Plan.
Mihály Kaszás, C.E.O. of TEVA said that the firm spent 200 billion Forints for various developments in the last 20 years. At that time the production of pills and capsules was increased from 0,5 billion to 10 billion at the factory that is located in Debrecen.
Kaszás also mentioned that the revenues of the firm were more than 150 billion Forints last year.
Source: mti.hu
